Z Squared to List on Nasdaq as ZSQR Upon Merger Close with Coeptis Therapeutics
Summary
Z Squared, the entity merging with Coeptis Therapeutics, is set to list on Nasdaq under the ticker ZSQR, effective upon the close of their pending merger. This development provides a crucial update to the "transformational merger" previously disclosed in Coeptis Therapeutics' 10-K filing on March 19, 2026. The 10-K also highlighted a going concern warning, making progress on this merger particularly significant. This news clarifies the post-merger operational structure and listing details, which is material for a company undergoing such a substantial change. Traders will now focus on the definitive closing date of the merger.
At the time of this announcement, COEP was trading at $11.54 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $71.8M. The 52-week trading range was $6.26 to $21.41. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.